Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma‐derived products
Tóm tắt
Từ khóa
Tài liệu tham khảo
CPMP:, 1996, CPMP Note for Guidance on Virus Validation Studies: the Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses.
Center for Biologics Evaluation and Research:, 2003, Final Guidance. Revised Recommendations for the Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection.
Center for Biologics Evaluation and Research:, 2002, Workshop on Development of Donor Screening Assays for West Nile Virus.
American Association of Blood Banks:, 2003, Recommended Guidance for Reporting West Nile Viremic Blood Donors to State and/or Local Public Health Departments and Reporting Donors Who Subsequently Develop West Nile Virus Illness to Blood Collection Agencies.
CPMP:, 2003, CPMP Position Statement on West Nile Virus and Plasma‐Derived Medicinal Products.
Centers for Disease Control and Prevention:, 2003, Updated interim CDC Guidance for Use of Smallpox Vaccine, Cidofovir, and Vaccinia Immune Globulin (VIG) for Prevention and Treatment in the Setting of an Outbreak of Monkeypox Infections.
Center for Biologics Evaluation and Research:, 2002, Final Guidance. Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia virus) and Certain Contacts of Smallpox Vaccine Recipients.
Cavalli‐Sforza L, 1969, Biometrie Grundzuge Biologisch‐Medizinischer Statistik [Biometry, the Basics of Biological and Medical Statistics], Gustav Fischer Verlag Stuttgart, 171
Anon:, 1994, Joint Announcement of the Federal Health Office and the Paul Ehrlich Institute Federal Office for Sera and Vaccines: Requirements for Validation Studies to Demonstrate the Virus Safety of Drugs Derived from Human Blood or Plasma, Federal Gazette, 84, 1